Michael Cornforth

Michael Cornforth

Oprichter bij KromaTid, Inc.

Health Technology

Oorsprong van het eerstegraads netwerk van Michael Cornforth

EntiteitType entiteitIndustrie
14
Holding Company Pharmaceuticals: Major 14

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Michael Cornforth via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
ABBOTT LABORATORIES Medical Specialties

Terry Opgenorth

Corporate Officer/Principal

PFIZER, INC. Pharmaceuticals: Major

Nicholas A. Saccomano

Corporate Officer/Principal

ARRAY TECHNOLOGIES, INC. Pharmaceuticals: Major

Nicholas A. Saccomano

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Nathan Wood

Director/Board Member

Medical/Nursing Services

James E. Chomas

Chief Executive Officer

Biotechnology

Nicholas A. Saccomano

Chief Executive Officer

Agricultural Commodities/Milling

Terry Opgenorth

Founder

NOVARTIS AG Pharmaceuticals: Major

Vic Myer

Director/Board Member

Industrial Machinery

James E. Chomas

Corporate Officer/Principal

The Trustees of Columbia University in The City of New York College/University

Nicholas A. Saccomano

Doctorate Degree

College/University

James E. Chomas

Undergraduate Degree

Investment Managers

Vic Myer

Consultant / Advisor

Calvin University College/University

Terry Opgenorth

Undergraduate Degree

Kalamazoo College College/University

Gretchen Pratt

Undergraduate Degree

Yale University College/University

Vic Myer

Doctorate Degree

College/University

Vic Myer

Undergraduate Degree

North Carolina State University College/University

Christopher Tompkins

Doctorate Degree

Oregon State University College/University

Nathan Wood

Undergraduate Degree

University of Illinois College/University

Terry Opgenorth

Doctorate Degree

Packaged Software

David Brunel

Chairman

Medical Specialties

David Brunel

Nicholas A. Saccomano

Founder

Chief Tech/Sci/R&D Officer

The State University of New York College/University

Nicholas A. Saccomano

Undergraduate Degree

Pharmaceuticals: Major

Nicholas A. Saccomano

Chief Tech/Sci/R&D Officer

Miscellaneous Commercial Services

Terry Opgenorth

Director/Board Member

Miscellaneous Commercial Services

Virginia Orndorff

James E. Chomas

Director/Board Member

Director/Board Member

Miscellaneous Commercial Services

Nathan Wood

Corporate Officer/Principal

Services to the Health Industry

James E. Chomas

Director/Board Member

Miscellaneous Commercial Services

Terry Opgenorth

Director/Board Member

Biotechnology

Vic Myer

Corporate Officer/Principal

Investment Managers

Nicholas A. Saccomano

Private Equity Investor

Pharmaceuticals: Major

James E. Chomas

Chief Executive Officer

Medical/Nursing Services

Terry Opgenorth

Director/Board Member

Colorado Institute

Terry Opgenorth

Director/Board Member

Medical/Nursing Services

Virginia Orndorff

Terry Opgenorth

Chief Executive Officer

Director/Board Member

EDITAS MEDICINE, INC. Biotechnology

Vic Myer

Chief Tech/Sci/R&D Officer

Pharmaceuticals: Generic

Terry Opgenorth

Chief Executive Officer

Pharmaceuticals: Major

Terry Opgenorth

Director/Board Member

Biotechnology

Jack Ball

Director/Board Member

Pharmaceuticals: Major

F. Andrew Ray

Director/Board Member

ELANCO ANIMAL HEALTH INCORPORATED Biotechnology

Terry Opgenorth

Corporate Officer/Principal

Standards Coordinating Body

Vic Myer

Director/Board Member

Pharmaceuticals: Major

Vic Myer

President

Financial Conglomerates

Terry Opgenorth

Director/Board Member

Biotechnology

Terry Opgenorth

Chairman

Biotechnology

Nicholas A. Saccomano

Director/Board Member

Biotechnology

Jack Ball

Nathan Wood

Director/Board Member

President

Statistieken

Internationaal

Verenigde Staten 50
Zwitserland 2

Sectoraal

Health Technology 22
Consumer Services 11
Commercial Services 7
Health Services 5
Finance 4

Operationeel

Director/Board Member 48
Corporate Officer/Principal 18
Chief Executive Officer 15
Founder 11
President 11
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU